52 POSTER Preclinical development of PTC299: an orally bioavailable small molecule drug that selectively inhibits the production of VEGF protein, tumor growth, and microvessel density
T. Davis, L. Cao, N. Tamilarasu, N. Risher, H. Qi, C. Romfo, J. Bombard, J. Sheedy, M. Weetall, Y. MoonVolume:
4
Year:
2006
Language:
english
DOI:
10.1016/s1359-6349(06)70058-1
File:
PDF, 59 KB
english, 2006